1. Symptom-adjusted therapy in asthma: it is time to listen to our patients
- Author
-
William J. Calhoun and K. Deepa Bhat
- Subjects
medicine.medical_specialty ,Asthma therapy ,business.industry ,Immunology ,Complex disease ,Inhaled corticosteroids ,medicine.disease ,Combined Modality Therapy ,Asthma ,Rescue treatment ,respiratory tract diseases ,Treatment Outcome ,medicine ,Humans ,Immunology and Allergy ,Anti-Asthmatic Agents ,Approaches of management ,Intensive care medicine ,business ,Lung function - Abstract
Expert Rev. Clin. Immunol. 7(3), 259–261 (2011) Asthma is a complex disease and is often difficult to treat owing to its heterogeneity. Guidelines for asthma have been established [1,101], providing a standard management approach in order to offer higher quality treatment. Current guidelines primarily rely on inhaled corticosteroids (ICSs), which are known to be effective in controlling symptoms, improving lung function and preventing mortality. However, asthma continues to be treated suboptimally [2], probably because managing asthma according to the guidelines can be both complicated
- Published
- 2011